976
Views
124
CrossRef citations to date
0
Altmetric
Original Research

Cannabis as a substitute for prescription drugs – a cross-sectional study

, &
Pages 989-998 | Published online: 02 May 2017

References

  • NCSL [webpage on the Internet]State Medical Marijuana Laws Available from: http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspxAccessed January 13, 2017
  • National Academies of Sciences, Engineering, and MedicineThe Health Effects of Cannabis and CannabinoidsWashington, DCNational Academies Press2017
  • Center for Behavioral Health Statistics and QualityResults from the 2015 National Survey on Drug Use and Health: Detailed Tables Prevalence Estimates, Standard Errors, P Values, and Sample SizesRockville, MDCenter for Behavioral Health Statistics and Quality2015
  • BradfordACBradfordWDMedical marijuana laws reduce prescription medication use in Medicare part DHealth Aff (Millwood)20163571230123627385238
  • DowellDHaegerichTMChouRCDC guideline for prescribing opioids for chronic pain – United States, 2016MMWR Recomm Rep2016651149
  • SextonMCuttlerCFinnellJSMischleyLKA cross-sectional survey of medical cannabis users: patterns of use and perceived efficacyCannabis Cannabinoid Res201611131138
  • HaroutounianSRatzYGinosarYThe effect of medicinal cannabis on pain and quality-of-life outcomes in chronic painClin J Pain201632121036104326889611
  • WalshZCallawayRBelle-IsleLCannabis for therapeutic purposes: patient characteristics, access, and reasons for useInt J Drug Policy201324651151624095000
  • HazekampAWareMAMuller-VahlKRAbramsDGrotenhermenFThe medicinal use of cannabis and cannabinoids – an international cross-sectional survey on administration formsJ Psychoactive Drugs201345319921024175484
  • WebbCWWebbSMTherapeutic benefits of cannabis: a patient surveyHawaii J Med Public Health201473410911124765558
  • ReinarmanCNunbergHLanthierFHeddlestonTWho are medical marijuana patients? Population characteristics from nine California assessment clinicsJ Psychoactive Drugs201143212813521858958
  • BarnwellSEarleywineMWilcoxRCannabis, motivation, and life satisfaction in an internet sampleSubst Abuse Treat Prev Policy200611216722561
  • ReimanAMedical cannabis patients: patient profiles and health care utilization patternsComplement Health Pract Rev20071213150
  • Survey of Cannabis Use, 2013 Available from: https://bastyr.edu/research/studies/survey-cannabis-use
  • HarrisPATaylorRThielkeRPayneJGonzalezNCondeJGResearch electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics supportJ Biomed Inform200942237738118929686
  • HaysRDBjornerJRevickiRASpritzerKLCellaDScoring PROMIS global short form development of physical and mental health summary scores from the Patient Reported Outcomes Measurement Information System (PROMIS) global items Estimating EuroQoL (EQ-5D) Index ScoresQual Life Res200918787388019543809
  • LucasPReimanAEarleywineMCannabis as a substitute for alcohol and other drugs: a dispensary-based survey of substitution effect in Canadian medical cannabis patientsAddict Res Theory2013215435442
  • LucasPWalshZCrosbyKSubstituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: the impact of contextual factorsDrug Alcohol Rev201635332633326364922
  • LucasPWalshZMedical cannabis access, use, and substitution for prescription opioids and other substances: a survey of authorized medical cannabis patientsInt J Drug Policy201742303528189912
  • BoehnkeKFLitinasEClauwDJMedical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic painJ Pain201617673974427001005
  • DaleRStaceyBMultimodal treatment of chronic painMed Clin North Am20161001556426614719
  • WalshZGonzalezRCrosbyKS ThiessenMCarrollCBonn-MillerMOMedical cannabis and mental health: a guided systematic reviewClin Psychol Rev201751152927816801
  • ChooEKFeldstein EwingSWLovejoyTIOpioids out, cannabisJAMA201631617176327802551
  • ĆurkovićMDodig-ĆurkovićKErićAPKralikKPivacNPsychotropic medications in older adults: a reviewPsychiatr Danub20162811324
  • LiuGGChristensenDBThe continuing challenge of inappropriate prescribing in the elderly: an update of the evidenceJ Am Pharm Assoc (Wash)200242684785712482007
  • HillKPMedical marijuana for treatment of chronic pain and other medical and psychiatric problemsJAMA201531324247426103031
  • CuttlerCMischleyLKSextonMSex differences in cannabis use and effects: a cross-sectional survey of cannabis usersCannabis Cannabinoid Res201611166175
  • CraftRMMarusichJAWileyJLSex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?Life Sci2013928–947648122728714
  • FattoreLFrattaWHow important are sex differences in cannabinoid action?Br J Pharmacol2010160354454820590564
  • GorzalkaBBDangSSMinireview: endocannabinoids and gonadal hormones: bidirectional interactions in physiology and behaviorEndocrinology201215331016102422210740
  • WilkersonJLGhoshSMustafaMThe endocannabinoid hydrolysis inhibitor SA-57: intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in miceNeuropharmacology201711415616727890602
  • LauNSalesPAverillSMurphyFSatoS-OMurphySA safer alternative: cannabis substitution as harm reductionDrug Alcohol Rev201534665465925919477
  • CHULCLARKDANGSTMOpioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective studyJ Pain200671434816414554
  • GiummarraMJGibsonSJAllenARPichlerASArnoldCAPolypharmacy and chronic pain: harm exposure is not all about the opioidsPain Med201516347247925280054
  • PhillipsCJThe cost and burden of chronic painRev Pain20093125
  • GaskinDJRichardPThe economic costs of pain in the United StatesJ Pain201213871572422607834
  • de Mello SchierARde Oliveira RibeiroNPCoutinhoDSAntidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativaCNS Neurol Disord Drug Targets201413695396024923339
  • CamposACMoreiraFAGomesFVDel BelEAGuimaraesFSMultiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disordersPhilos Trans R Soc Lond B Biol Sci201236716073364337823108553
  • GomesFVResstelLBMGuimarãesFSThe anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptorsPsychopharmacology (Berl)20112132–346547320945065
  • BhattacharyyaSFusar-PoliPBorgwardtSModulation of medio temporal and ventrostriatal function in humans by Δ9-tetrahydro-cannabinolArch Gen Psychiatry200966444219349314
  • GaetaniSDipasqualePRomanoAChapter 5 the endocannabinoid system as a target for novel anxiolytic and antidepressant drugsInt Rev Neurobiol200985577219607961
  • SchierARRibeiroNPSilvaACCannabidiol, a Cannabis sativa constituent, as an anxiolytic drugRev Bras Psiquiatr201234suppl 1S104S11022729452
  • LazaryJEszlariNJuhaszGBagdyGGenetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood traumaEur Neuropsychopharmacol20162661020102827005594
  • GrayJMWilsonCDLeeTTYSustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid functionPsychoneuroendocrinology20166615115826821211
  • GobiraPHAlmeida-SantosAFGuimaraesFSMoreiraFAAguiarDCRole of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal greyAllergol Immunopathol (Madr)20162611522
  • OsbornLALauritsenKJCrossNSelf-medication of somatic and psychiatric conditions using botanical marijuanaJ Psychoactive Drugs201547534535026595140
  • JohnstonBCPatrickDLBusseJWSchünemannHJAgarwalAGuyattGHPatient-reported outcomes in meta-analyses – part 1: assessing risk of bias and combining outcomesHealth Qual Life Outcomes20131110923815754
  • BaschEBoltDMDengSThe missing voice of patients in drug-safety reportingN Engl J Med20103621086586920220181
  • CDC [webpage on the Internet]Opioid Painkiller Prescribing | Vital Signs | CDC Available from: https://www.cdc.gov/vitalsigns/opioid-prescribing/Accessed February 1, 2017
  • Center for Behavioral Health Statistics and Quality [webpage on the Internet]Key substance use and mental health indicators in the United States: results from the 2015 National Survey on Drug Use and Health (HHS Publication No. SMA 16-4984, NSDUH Series H-51)2016 Available from: http://www.samhsa.gov/data/212017
  • Centers for Disease Control and Prevention, National Center for Injury Prevention and Control D of UIP [webpage on the Internet]Understanding the Epidemic | Drug Overdose | CDC Injury Center2016 Available from: https://www.cdc.gov/drugoverdose/epidemic/Accessed February 1, 2017